Trial intelligence / Profile preview

LCZ696 PK/PD in Stable Heart Failure

NCT00913653Phase 2Completed

Sponsor
Novartis
Start
May 2009
Primary completion
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sacubitril + valsartan in heart failure (HF), sponsored by Novartis. Started May 2009; status: completed.

02

Drugs

sacubitril + valsartan
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00913653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00913653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call